We are live on ! Find out more
DY

Dowling & Yahnke Portfolio holdings

AUM $2.15B
1-Year Est. Return 10.82%
This Fund
S&P 500
This Quarter Est. Return
+9.47%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
–
AUM
$2.08B
AUM Growth
+$273M
Cap. Flow
+$118M
Cap. Flow %
5.69%
Top 10 Hldgs %
26.49%
Holding
390
New
18
Increased
114
Reduced
180
Closed
13

Top Buys

Rank Stock Value
1
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$30.1M
2
RVTY icon
Revvity
RVTY
+$25.4M
3
VXUS icon
Vanguard Total International Stock ETF
VXUS
+$15.6M
4
BND icon
Vanguard Total Bond Market
BND
+$13.3M
5
DFAC icon
Dimensional US Core Equity 2 ETF
DFAC
+$10.4M

Top Sells

Rank Stock Value
1
SOXX icon
iShares Semiconductor ETF
SOXX
+$1.72M
2
DFUS
Dimensional US Equity ETF
DFUS
+$1.68M
3
DFAS icon
Dimensional US Small Cap ETF
DFAS
+$1.36M
4
O icon
Realty Income
O
+$1.05M
5
MZTI
The Marzetti Company
MZTI
+$936K

Sector Composition

Rank Sector Weight
1 Miscellaneous 36.53%
2 Technology 15.7%
3 Healthcare 10.65%
4 Financials 8.79%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STAB
376
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$34K ﹤0.01%
14,675
– –
RGLS
377
DELISTED
Regulus Therapeutics
RGLS
$4K ﹤0.01%
1,200
– –
ARCC icon
378
Ares Capital
ARCC
$14.3B
– –
-10,620
Closed -$216K
ARKK icon
379
ARK Innovation ETF
ARKK
$6.46B
– –
-6,289
Closed -$695K
BCAB icon
380
BioAtla
BCAB
$2.9M
– –
-152
Closed -$224K
BIV icon
381
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
– –
-4,129
Closed -$369K
IYF icon
382
iShares US Financials ETF
IYF
$4.31B
– –
-2,470
Closed -$204K
MFC icon
383
Manulife Financial
MFC
$70.9B
– –
-14,938
Closed -$287K
MUB icon
384
iShares National Muni Bond ETF
MUB
$45.5B
– –
-2,128
Closed -$247K
NAC icon
385
Nuveen California Quality Municipal Income Fund
NAC
$1.83B
– –
-11,588
Closed -$182K
TROW icon
386
T. Rowe Price
TROW
$23.7B
– –
-1,110
Closed -$218K
VCYT icon
387
Veracyte
VCYT
$3.48B
– –
-4,400
Closed -$204K
TWTR
388
DELISTED
Twitter, Inc.
TWTR
– –
-3,434
Closed -$207K
ADMS
389
DELISTED
Adamas Pharmaceuticals
ADMS
– –
-16,000
Closed -$79K
GPX
390
DELISTED
GP Strategies Corp.
GPX
– –
-13,040
Closed -$270K
12 13 14 15
16

Similar funds

AC
Alleghany Corporation New York $2.21B AUM 10.5% 1-Year Est. Return
CCM
Covington Capital Management Los Angeles, California $2.32B AUM 12.18% 1-Year Est. Return
MIAN
Mariner Independent Advisor Network Overland Park, Kansas $2.33B AUM 14.85% 1-Year Est. Return
APA
American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return
IC
Inverness Counsel New York $1.8B AUM 9.9% 1-Year Est. Return
SCA
Salient Capital Advisors Houston, Texas $1.74B AUM 12.95% 1-Year Est. Return
ACM
AlphaCrest Capital Management New York $1.64B AUM 23.4% 1-Year Est. Return
W
Wealthsimple Toronto, Ontario, Canada $2.69B AUM 18.39% 1-Year Est. Return

Dowling & Yahnke's Q4 2021 Portfolio in Review

As of Q4 2021, Dowling & Yahnke held 390 positions worth $2.08B, up 15% from $1.81B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Dowling & Yahnke deployed $118M of net new capital in Q4 2021, opening 18 new positions and adding to 114 existing holdings. Its largest new stake was Revvity: 140,556 shares worth $28.3M.

By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, up from 34% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was iShares Semiconductor ETF, an estimated $1.72M trimmed.

  • Dowling & Yahnke's largest Q4 2021 buy was Revvity: 140,556 shares worth $28.3M.
  • Dowling & Yahnke added most to Vanguard Short-Term Bond ETF in Q4 2021, an estimated $30.1M increase.
  • Dowling & Yahnke's biggest Q4 2021 reduction was iShares Semiconductor ETF, cutting an estimated $1.72M.
  • Dowling & Yahnke fully exited ARK Innovation ETF in Q4 2021, selling an estimated $695K.
  • Dowling & Yahnke's ten largest holdings make up 26% of its $2.08B portfolio in Q4 2021.
  • Dowling & Yahnke opened 18 new positions and closed 13 in Q4 2021.
  • Dowling & Yahnke's portfolio value rose 15% quarter-over-quarter to $2.08B.

Based on Dowling & Yahnke's 13F filing for Q4 2021, filed 10 Feb 2022.